You are here

Article info

Article menu

Download PDFPDF

XML
Neuro-inflammation
Review
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes

Authors

  • Sophie N M Binks Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK PubMed articlesGoogle scholar articles
  • Christopher J Klein Department of Neurology, Neuroimmunology Laboratory, Mayo Clinic, Rochester, Minnesota, USA Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Patrick Waters Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK PubMed articlesGoogle scholar articles
  • Sean J Pittock Department of Neurology, Neuroimmunology Laboratory, Mayo Clinic, Rochester, Minnesota, USA Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Sarosh R Irani Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK Department of Neurology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Sarosh R Irani, Autoimmune Neurology Group, John Radcliffe Hospital, Oxford OX3 9DS, UK; sarosh.irani{at}ndcn.ox.ac.uk
View Full Text

Citation

Binks SNM, Klein CJ, Waters P, et al
LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
Journal of Neurology, Neurosurgery & Psychiatry 2018;89:526-534.

Publication history

  • Received August 13, 2017
  • Revised September 21, 2017
  • Accepted September 22, 2017
  • First published October 21, 2017.
Online issue publication 
April 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/